Qualigen Therapeutics Inc (QLGN)
4.29
+0.11
(+2.71%)
USD |
NASDAQ |
Nov 14, 12:16
Qualigen Therapeutics Total Assets (Quarterly): 0.5344M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.5344M |
| March 31, 2024 | 1.003M |
| December 31, 2023 | 2.033M |
| September 30, 2023 | 4.316M |
| June 30, 2023 | 13.15M |
| March 31, 2023 | 15.91M |
| December 31, 2022 | 19.08M |
| September 30, 2022 | 22.96M |
| Date | Value |
|---|---|
| June 30, 2022 | 26.35M |
| March 31, 2022 | 18.71M |
| December 31, 2021 | 22.84M |
| September 30, 2021 | 16.40M |
| June 30, 2021 | 19.89M |
| March 31, 2021 | 25.74M |
| September 30, 2020 | 20.68M |
| June 30, 2020 | 8.679M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.5344M
Minimum
Jun 2024
26.35M
Maximum
Jun 2022
14.89M
Average
17.56M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.812M |
| Shareholders Equity (Quarterly) | -4.278M |